Advertisement
Advertisement

ALDX

ALDX logo

Aldeyra Therapeutics, Inc.

1.90
USD
Sponsored
-0.12
-5.94%
Jun 24, 16:00 UTC -4
Closed
exchange

Pre-Market

1.95

+0.05
+2.58%

ALDX Earnings Reports

Positive Surprise Ratio

ALDX beat 25 of 42 last estimates.

60%

Next Report

Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.10
Implied change from Q1 26 (Revenue/ EPS)
--
/
+66.67%
Implied change from Q2 25 (Revenue/ EPS)
--
/
-23.08%

Aldeyra Therapeutics, Inc. earnings per share and revenue

On May 07, 2026, ALDX reported earnings of -0.06 USD per share (EPS) for Q1 26, beating the estimate of -0.09 USD, resulting in a 39.70% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.93% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.10 USD, with revenue projected to reach -- USD, implying an increase of 66.67% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
For Q1 2026, Aldeyra Therapeutics, Inc. reported EPS of -$0.06, beating estimates by 39.7%, and revenue of $0.00, 0% as expectations.
The stock price moved up 2.93%, changed from $5.46 before the earnings release to $5.62 the day after.
The next earning report is scheduled for Aug 05, 2026.
Based on 4 analysts, Aldeyra Therapeutics, Inc. is expected to report EPS of -$0.10 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement